Global Conjunctivitis Market 2015-2019 - Product Image

Global Conjunctivitis Market 2015-2019

  • ID: 3608956
  • Report
  • Region: Global
  • 72 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Akorn
  • Allergan
  • Celsus Therapeutics
  • Griffin Discoveries
  • Merck
  • NovaBay
  • MORE
About Conjunctivitis

Conjunctivitis, also called pink eye or Madras eye, is an infection in or inflammation of the conjunctiva. It affects either one or both a person's eyes and can be the result of an allergy, bacteria, or a virus. Allergens such as smoke, pollen, dust mites, eye drops, cosmetics, and perfumes can lead to conjunctivitis. It is usually associated with redness of the eye along with the release of mucoid discharges. Although the condition usually heals without medication, antibiotics are commonly used for treatment to avoid complications due to irritation of the eye.

The analysts forecast the global conjunctivitis medication market to grow at a CAGR of 1.94% during the period 2015-2019.

Covered in this report
The report covers the present scenario and the growth prospects of the global conjunctivitis medication market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of various prescription medication along with the over-the-counter (OTC) medication used to treat bacterial, viral, and allergic conjunctivitis.

The market is divided into the following segments based on geography:
- APAC
- EMEA
- Americas

The report, Global Conjunctivitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Akorn
- Alcon
- Allergan
- Bausch & Lomb

Other prominent vendors
- Celsus Therapeutics
- Eleven Biotherapeutics
- Griffin Discoveries
- InSite Vision
- Merck
- Nicox
- NovaBay
- Ocular Therapeutix
- Santen Pharmaceutical
- Shire (Foresight Biotherapeutics)
- Starpharma
- Sun Pharmaceutical

Market drivers
- Increased exposure to chemicals and pollutants
- For a full, detailed list, view the full report

Market challenges
- Patent expiry of medication
- For a full, detailed list, view the full report

Market trends
- Strategic alliances and M&A
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Akorn
  • Allergan
  • Celsus Therapeutics
  • Griffin Discoveries
  • Merck
  • NovaBay
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Overview: Conjunctivitis
  • Types of conjunctivitis
  • Signs and symptoms
  • Diagnosis
PART 06: Pipeline analysis
  • AC-170
  • AGN-229666
  • DEXTENZA
  • SUN-1334H
  • Auriclosene
  • EBI-005
  • FST-100
  • SPL7013
  • OPX-1
  • AzaSite Xtra (ISV-405)
  • GD134
PART 07: Market landscape
  • Market overview
  • Market size and forecast
  • Conjunctivitis medication market in the US
  • Bacterial conjunctivitis medication market in the US
  • Viral conjunctivitis medication market in the US
  • Allergic conjunctivitis medication market in the US
  • Five forces analysis
PART 08: Market segmentation based on condition type
  • Bacterial conjunctivitis medication
  • Viral conjunctivitis medication
  • Allergic conjunctivitis medication
  • Global bacterial conjunctivitis medication market
  • Global viral conjunctivitis medication market
  • Global allergic conjunctivitis medication market
PART 09: Geographical segmentation
  • Geographical segmentation of global conjunctivitis medication market
  • Conjunctivitis medication market in the Americas
  • Conjunctivitis medication market in EMEA
  • Conjunctivitis medication market in APAC
PART 10: Market drivers
  • Increased exposure to chemicals and pollutants
  • Rising awareness of condition
  • Exploring specific treatment for viral conjunctivitis
  • Tentative approval of pipeline candidates
PART 11: Impact of drivers

PART 12: Market challenges
  • Patent expiry of medication
  • Contentment with existing therapies
  • Adverse effects and limited efficacy of medication
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Strategic alliances and M&A
  • Use of combination therapies
  • Increased R&D
PART 15: Vendor landscape
  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors
PART 16: Key vendor analysis
  • Akorn
  • Alcon
  • Allergan
  • Bausch & Lomb
PART 17: Appendix
  • List of abbreviations
PART 18: About the Author

Exhibit 01: Product offerings
Exhibit 02: Causes of conjunctivitis
Exhibit 03: Types of bacterial conjunctivitis
Exhibit 04: Types of viral conjunctivitis
Exhibit 05: Types of allergic conjunctivitis
Exhibit 06: Signs and symptoms of common forms of conjunctivitis
Exhibit 07: Medication used for treatment of conjunctivitis
Exhibit 08: Global conjunctivitis market: Pipeline portfolio
Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions)
Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions)
Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US
Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014
Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019
Exhibit 17: Five forces analysis
Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type
Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014
Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions)
Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019
Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014
Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions)
Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions)
Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions)
Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019
Exhibit 29: Impact of drivers
Exhibit 30: Impact of drivers and challenges
Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions)
Exhibit 32: Akorn: Key takeaways
Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014
Exhibit 35: Alcon: Key takeaways
Exhibit 36: Allergan: Key takeaways
Exhibit 37: Allergan: Business segmentation 2014 by revenue
Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Allergan: Geographical segmentation by revenue 2014
Exhibit 40: Bausch & Lomb: Product categories
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Akorn
  • Allergan
  • Celsus Therapeutics
  • Griffin Discoveries
  • Merck
  • NovaBay
  • MORE
New Report Released: – Global Conjunctivitis Market 2015-2019

The author of the report recognizes the following companies as the key players in the Global Conjunctivitis Market: Akorn, Alcon, Allergan and Bausch & Lomb

Other Prominent Vendors in the market are: Celsus Therapeutics, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Merck, Nicox, NovaBay, Ocular Therapeutix, Santen Pharmaceutical, Shire (Foresight biotherapeutics), Starpharma, and Sun Pharma.

Commenting on the report, an analyst from the research team said: “M&A between companies is expected to increase the market penetration of conjunctivitis medication, stimulating the growth of the market. Combination therapy is also an efficacious treatment option for individuals affected by conjunctivitis.”

According to the report, increased exposure to harmful pollutants and chemicals is leading to a rise in the number of conjunctivitis cases worldwide. People working in chemical factories and those exposed to automobile exhaust tend to acquire allergic conjunctivitis. The rising awareness of the condition and its treatment options are driving market growth.

Further, the report states that as patents of existing therapies expire, genericization of treatment medication is expected to occur. This will lead to the entry of low-cost generics into the market, reducing overall revenue. In addition, the reluctance of physicians toward the acceptance of new therapies is a challenge to market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Akorn
- Alcon
- Allergan
- Bausch & Lomb
- Celsus Therapeutics
- Eleven Biotherapeutics
- Griffin Discoveries
- InSiteVision
- Merck
- Nicox
- NovaBay
- Ocular Therapeutix
- Santen Pharmaceutical
- Shire (Foresight biotherapeutics)
- Starpharma
- Sun Pharma.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll